The antiviral - brincidofovir - is being tested on Ebola patients on a voluntary basis. People who do not consent to it receive standard care. Oxford University scientists leading the research say initial results are expected in the next few months. via Pocket http://ift.tt/1DhGdBr
No comments:
Post a Comment